MC
VRTX icon

Miles Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Miles Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$394K Buy
1,657
+334
+25% +$76.6K 0.42% 65
2019
Q4 		$290K Sell
1,323
-68
-5% -$13.8K 0.23% 110
2019
Q3 		$236K Sell
1,391
-2
-0.1% -$354 0.19% 137
2019
Q2 		$255K Buy
1,393
+169
+14% +$29.5K 0.21% 127
2019
Q1 		$225K Sell
1,224
-125
-9% -$23.1K 0.2% 144
2018
Q4 		$224K Buy
1,349
+7
+0.5% +$1.21K 0.22% 133
2018
Q3 		$259K Buy
+1,342
New +$239K 0.21% 132

Other funds holding VRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return